GTNF 2022 Review – Accessing Innovation
October 4, 2022
The Broughton team were at the prestigious Four Seasons hotel in Georgetown, Washington DC for this year’s Global Tobacco and Nicotine ...
Modern Oral Nicotine Products need clear ...
July 7, 2022
Modern Oral Nicotine Products (MONPs) are another exciting product innovation that can support the cause of worldwide tobacco harm ...
Positive steps but still many challenges - the ...
July 4, 2022
Broughton's Chief Executive Officer, Chris Allen summarizes the highlights from Global Forum on Nicotine (GFN).
Broughton shares the highlights from Next ...
June 24, 2022
Broughton's Chief Commercial Officer, Andy Mooney summarizes the highlights from Next Generation Nicotine Delivery Conference USA.
FDA PMTA 90-day deficiency letters – what next?
June 1, 2021
Broughton Head of Scientific Affairs, Paul Hardman outlines factors that can lead to data gaps in Premarket Tobacco Product Applications ...
What’s next for Tobacco Use and Next Generation ...
March 5, 2021
Broughton Dr Nveed Chaudhary, Chief Regulatory Officer discusses the EU's stance on Next Generation Products and what this means for ...
